THE latest issue of the NPS
Radar has been released online,
containing independent, evidencebased
assessments of new drugs
and new PBS listings.
This month’s issue covers two of
the new class of dipeptidyl
peptidase-4 (DPP-4) inhibitors
sitagliptin (Januvia) and vildagliptin
(Galvus), as well as the new
autoinjector Anapen and reviews
and info on Panadol Extra,
Colchicine for acute gout,
pramipexole (Sifrol ER), Anakinra
(Kineret) and Exenatide (Byetta).
See www.nps.org.au/radar.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Aug 10
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.